[1]
Siegel, R.L.; Miller, K.D.; Jemal, A.; Fedewa, S.A.; Butterly, L.F.; Anderson, J.C.; Cercek, A.; Smith, R.A.; Jemal, A. Cancer statistics, 2020. Ca Cancer J. Clin., 2020, 70(1), 7-30. [http://dx.doi.org/10.3322/caac.21590]. [PMID: 31912902].
[2]
Zheng, M. Classification and pathology of lung cancer. Surg. Oncol. Clin. Am., 2016, 25(3), 447-468. [http://dx.doi.org/10.1016/j.soc.2016.02.003]. [PMID: 27261908].
[3]
Calvayrac, O.; Pradines, A.; Pons, E.; Mazières, J.; Guibert, N. Molecular biomarkers for lung adenocarcinoma. Eur. Respir. J., 2017, 49(4)1601734 [http://dx.doi.org/10.1183/13993003.01734-2016]. [PMID: 28381431].
[4]
Xue, C.; Hu, Z.; Jiang, W.; Zhao, Y.; Xu, F.; Huang, Y.; Zhao, H.; Wu, J.; Zhang, Y.; Zhao, L.; Zhang, J.; Chen, L.; Zhang, L. National survey of the medical treatment status for non-small cell lung cancer (NSCLC) in China. Lung Cancer, 2012, 77(2), 371-375. [http://dx.doi.org/10.1016/j.lungcan.2012.04.014]. [PMID: 22579298].
[5]
Huang, P.; Cao, K.; Zhao, H. Screening of critical genes in lung adenocarcinoma via network analysis of gene expression profile. Pathol. Oncol. Res., 2014, 20(4), 853-858. [http://dx.doi.org/10.1007/s12253-014-9764-z]. [PMID: 24859971].
[6]
Möröy, T.; Geisen, C.; Cyclin, E.; Cyclin, E. Int. J. Biochem. Cell Biol., 2004, 36(8), 1424-1439. [http://dx.doi.org/10.1016/j.biocel.2003.12.005]. [PMID: 15147722].
[7]
Nakayama, N.; Nakayama, K.; Shamima, Y.; Ishikawa, M.; Katagiri, A.; Iida, K.; Miyazaki, K. Gene amplification CCNE1 is related to poor survival and potential therapeutic target in ovarian cancer. Cancer, 2010, 116(11), 2621-2634.
[8]
Shariat, S.F.; Ashfaq, R.; Sagalowsky, A.I.; Lotan, Y. Correlation of cyclin D1 and E1 expression with bladder cancer presence, invasion, progression, and metastasis. Hum. Pathol., 2006, 37(12), 1568-1576. [http://dx.doi.org/10.1016/j.humpath.2006.05.017]. [PMID: 16949911].
[9]
Kim, B.; Shin, H.C.; Heo, Y.J.; Ha, S.Y.; Jang, K.T.; Kim, S.T.; Kang, W.K.; Lee, J.; Kim, K.M. CCNE1 amplification is associated with liver metastasis in gastric carcinoma. Pathol. Res. Pract., 2019, 215(8)152434 [http://dx.doi.org/10.1016/j.prp.2019.152434]. [PMID: 31178228].
[10]
Zhao, Z.M.; Yost, S.E.; Hutchinson, K.E.; Li, S.M.; Yuan, Y.C.; Noorbakhsh, J.; Liu, Z.; Warden, C.; Johnson, R.M.; Wu, X.; Chuang, J.H.; Yuan, Y. CCNE1 amplification is associated with poor prognosis in patients with triple negative breast cancer. BMC Cancer, 2019, 19(1), 96. [http://dx.doi.org/10.1186/s12885-019-5290-4]. [PMID: 30665374].
[11]
Zhao, H.; Wang, J.; Zhang, Y.; Yuan, M.; Yang, S.; Li, L.; Yang, H. Prognostic values of ccne1 amplification and overexpression in cancer patients: A systematic review and meta-analysis. J. Cancer, 2018, 9(13), 2397-2407. [http://dx.doi.org/10.7150/jca.24179]. [PMID: 30026836].
[12]
Han, Z.; Zhang, Y.; Yang, Q.; Liu, B.; Wu, J.; Zhang, Y.; Yang, C.; Jiang, Y. Mir-497 and mir-34a retard lung cancer growth by co-inhibiting cyclin E1 (ccne1). Oncotarget, 2015, 6(15), 13149-13163. [http://dx.doi.org/10.18632/oncotarget.3693]. [PMID: 25909221].
[13]
Koutsami, M.K.; Tsantoulis, P.K.; Kouloukoussa, M.; Apostolopoulou, K.; Pateras, I.S.; Spartinou, Z.; Drougou, A.; Evangelou, K.; Kittas, C.; Bartkova, J.; Bartek, J.; Gorgoulis, V.G. Centrosome abnormalities are frequently observed in non-small-cell lung cancer and are associated with aneuploidy and cyclin E overexpression. J. Pathol., 2006, 209(4), 512-521. [http://dx.doi.org/10.1002/path.2005]. [PMID: 16739112].
[14]
Tsuta, K.; Kawago, M.; Yoshida, A.; Sekine, S.; Asamura, H.; Furuta, K.; Kushima, R. Primary lung adenocarcinoma with morule-like components: a unique histologic hallmark of aggressive behavior and egfr mutation. Lung Cancer, 2014, 85(1), 12-18. [http://dx.doi.org/10.1016/j.lungcan.2014.03.022]. [PMID: 24768118].
[15]
de Maturana, E.L.; Rava, M.; Anumudu, C.; Sáez, O.; Alonso, D.; Malats, N. Bladder cancer genetic susceptibility. a systematic review. Bladder Cancer, 2018, 4(2), 215-226. [http://dx.doi.org/10.3233/BLC-170159]. [PMID: 29732392].
[16]
Aziz, K.; Limzerwala, J.F.; Sturmlechner, I.; Hurley, E.; Zhang, C.; Jeganathan, K.B.; Nelson, G.; Bronk, S.; Fierro Velasco, R.O.; van Deursen, E.J.; O’Brien, D.R.; Kocher, J.A.; Youssef, S.A.; van Ree, J.H.; de Bruin, A.; van den Bos, H.; Spierings, D.C.J.; Foijer, F.; van de Sluis, B.; Roberts, L.R.; Gores, G.J.; Li, H.; van Deursen, J.M. Ccne1 overexpression causes chromosome instability in liver cells and liver tumor development in mice. Gastroenterology, 2019, 157(1), 210-226. [http://dx.doi.org/10.1053/j.gastro.2019.03.016]. [PMID: 30878468].
[17]
Zhang, C.; Zhu, Q.; Gu, J.; Chen, S.; Li, Q.; Ying, L. Down-regulation of ccne1 expression suppresses cell proliferation and sensitizes gastric carcinoma cells to cisplatin. Biosci. Rep., 2019, 39(6)BSR20190381 [http://dx.doi.org/10.1042/BSR20190381]. [PMID: 31072916].
[18]
Gurzov, E.N.; Izquierdo, M. Cyclin E1 knockdown induces apoptosis in cancer cells. Neurol. Res., 2006, 28(5), 493-499. [http://dx.doi.org/10.1179/016164106X115143]. [PMID: 16808878].